AIN/Sandipan Shringi
@nephrosage.bsky.social
AnotherIndianNephrologist @Nephrosage
CKD progression, kidney failure, and mortality among US patients with IgA nephropathy
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
CKD progression, kidney failure, and mortality among US patients with IgA nephropathy
ABSTRACTBackground and Hypothesis. We assessed disease progression among patients with immunoglobulin A nephropathy (IgAN) and characterized factors associ
academic.oup.com
November 14, 2025 at 1:08 PM
CKD progression, kidney failure, and mortality among US patients with IgA nephropathy
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
High measured GFR as a predictor of all-cause mortality and cardiovascular disease in a prospective non-diabetic population cohort
More info:https://academic.oup.com/ndt/article/40/11/2091/8122110
@ndt-era.bsky.social, @hjanders.bsky.social
More info:https://academic.oup.com/ndt/article/40/11/2091/8122110
@ndt-era.bsky.social, @hjanders.bsky.social
High measured GFR as a predictor of all-cause mortality and cardiovascular disease in a prospective non-diabetic population cohort
ABSTRACTBackground. High glomerular filtration rate (GFR) is generally regarded as beneficial but has been associated with cardiovascular disease (CVD) and
academic.oup.com
November 13, 2025 at 5:30 PM
High measured GFR as a predictor of all-cause mortality and cardiovascular disease in a prospective non-diabetic population cohort
More info:https://academic.oup.com/ndt/article/40/11/2091/8122110
@ndt-era.bsky.social, @hjanders.bsky.social
More info:https://academic.oup.com/ndt/article/40/11/2091/8122110
@ndt-era.bsky.social, @hjanders.bsky.social
A novel system to continuously estimate intradialytic blood pressure in real time
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
A novel system to continuously estimate intradialytic blood pressure in real time
ABSTRACTBackground. Intradialytic hypotension (IDH) is a common complication of haemodialysis that is associated with adverse patient outcomes. We have dev
academic.oup.com
November 12, 2025 at 3:08 PM
A novel system to continuously estimate intradialytic blood pressure in real time
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
Life support in hemodialysis emergencies—treatment standard
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
Life support in hemodialysis emergencies—treatment standard
ABSTRACT. Hemodialysis removes uremic toxins and excess water and sodium from the blood of patients with kidney failure. For the last 60 years, this techni
academic.oup.com
November 11, 2025 at 2:15 PM
Life support in hemodialysis emergencies—treatment standard
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
Cholinergic system in patients with chronic kidney disease: cognitive and renal implications
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
Cholinergic system in patients with chronic kidney disease: cognitive and renal implications
ABSTRACT. Cholinergic synapses are widespread throughout the human central nervous system. Their high density in the thalamus, neocortex, limbic system and
academic.oup.com
November 10, 2025 at 4:34 PM
Cholinergic system in patients with chronic kidney disease: cognitive and renal implications
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
Reposted by AIN/Sandipan Shringi
Late breakers that included children:
✅Setanaxib in Alport (12+)
Late breakers that did NOT include children:
🚫Atacicept in IgAN
🚫CONFIDENCE
🚫PISCES: Fish oil in Dialysis
🚫LIBERATE-D
🚫balcinrenone + dapa
🚫Obintuzumab in lupus nephritis
🚫Sibeprenlimab in IgA
🚫MIL62 in membranous
+more
#KidneyWk
✅Setanaxib in Alport (12+)
Late breakers that did NOT include children:
🚫Atacicept in IgAN
🚫CONFIDENCE
🚫PISCES: Fish oil in Dialysis
🚫LIBERATE-D
🚫balcinrenone + dapa
🚫Obintuzumab in lupus nephritis
🚫Sibeprenlimab in IgA
🚫MIL62 in membranous
+more
#KidneyWk
November 8, 2025 at 8:27 PM
Late breakers that included children:
✅Setanaxib in Alport (12+)
Late breakers that did NOT include children:
🚫Atacicept in IgAN
🚫CONFIDENCE
🚫PISCES: Fish oil in Dialysis
🚫LIBERATE-D
🚫balcinrenone + dapa
🚫Obintuzumab in lupus nephritis
🚫Sibeprenlimab in IgA
🚫MIL62 in membranous
+more
#KidneyWk
✅Setanaxib in Alport (12+)
Late breakers that did NOT include children:
🚫Atacicept in IgAN
🚫CONFIDENCE
🚫PISCES: Fish oil in Dialysis
🚫LIBERATE-D
🚫balcinrenone + dapa
🚫Obintuzumab in lupus nephritis
🚫Sibeprenlimab in IgA
🚫MIL62 in membranous
+more
#KidneyWk
Physical activity and cardiorenal health—from associations to interventional studies
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
Physical activity and cardiorenal health—from associations to interventional studies
ABSTRACT. Clustering of traditional and kidney-specific risk factors leads to elevated cardiovascular disease (CVD) risk across the trajectory of chronic k
academic.oup.com
November 7, 2025 at 1:08 PM
Physical activity and cardiorenal health—from associations to interventional studies
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
Trends in nephrology: from “diabetic kidney disease” to “CKD with risk factor diabetes”
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
Trends in nephrology: from “diabetic kidney disease” to “CKD with risk factor diabetes”
Diabetic kidney disease (DKD) is typically regarded as a linear complication of chronic hyperglycaemia, beginning with albuminuria, followed by reduced est
academic.oup.com
November 6, 2025 at 5:30 PM
Trends in nephrology: from “diabetic kidney disease” to “CKD with risk factor diabetes”
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
Moving beyond race, geographical origin and ethnicity: genomic insights as a path forward in nephrology care
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
Moving beyond race, geographical origin and ethnicity: genomic insights as a path forward in nephrology care
Although humans share 99.9% of their DNA, the concept of race continues to be prevalent in the medical literature. The enduring presence of this notion sug
academic.oup.com
November 5, 2025 at 3:08 PM
Moving beyond race, geographical origin and ethnicity: genomic insights as a path forward in nephrology care
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
The efficacy and safety of roxadustat for anemia in patients with chronic kidney disease: a meta-analysis
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
The efficacy and safety of roxadustat for anemia in patients with chronic kidney disease: a meta-analysis
AbstractBackground. Chronic kidney disease (CKD) is an increasing public health issue. Anemia, which is a complication of CKD, is associated with reduced q
academic.oup.com
October 27, 2025 at 3:34 PM
The efficacy and safety of roxadustat for anemia in patients with chronic kidney disease: a meta-analysis
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
The efficacy and safety of roxadustat for anemia in patients with chronic kidney disease: a meta-analysis
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
Validate User
academic.oup.com
October 24, 2025 at 12:08 PM
The efficacy and safety of roxadustat for anemia in patients with chronic kidney disease: a meta-analysis
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
Metagenomic profiling of gut microbiome in early chronic kidney disease
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
Metagenomic profiling of gut microbiome in early chronic kidney disease
AbstractBackground. The relationship between chronic kidney disease (CKD) and the gut microbiome, which interact through chronic inflammation, uraemic toxi
academic.oup.com
October 23, 2025 at 4:31 PM
Metagenomic profiling of gut microbiome in early chronic kidney disease
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
The genetics of steroid-resistant nephrotic syndrome in adults
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
Validate User
academic.oup.com
October 22, 2025 at 2:08 PM
The genetics of steroid-resistant nephrotic syndrome in adults
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
Dietary plant and animal protein intake and decline in estimated glomerular filtration rate among elderly women: a 10-year longitudinal cohort study
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
Validate User
academic.oup.com
October 21, 2025 at 1:15 PM
Dietary plant and animal protein intake and decline in estimated glomerular filtration rate among elderly women: a 10-year longitudinal cohort study
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
Individualizing renoprotective therapy in obesity and CKD: a commentary by the Diabesity Working Group of the ERA
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
October 16, 2025 at 4:31 PM
Individualizing renoprotective therapy in obesity and CKD: a commentary by the Diabesity Working Group of the ERA
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
Treatment of relapsing minimal change podocytopathy
More info: academic.oup.com/ndt/article-...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article-...
@ndt-era.bsky.social, @hjanders.bsky.social
October 15, 2025 at 2:08 PM
Treatment of relapsing minimal change podocytopathy
More info: academic.oup.com/ndt/article-...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article-...
@ndt-era.bsky.social, @hjanders.bsky.social
Cardio-kidney outcomes for combined versus monotherapy with finerenone or SGLT2 inhibitors in patients with CKD
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
October 14, 2025 at 1:16 PM
Cardio-kidney outcomes for combined versus monotherapy with finerenone or SGLT2 inhibitors in patients with CKD
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
lumasiran in primary hyperoxaluria type 1
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
October 13, 2025 at 3:34 PM
lumasiran in primary hyperoxaluria type 1
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
EKFC or CKD-EPIASR-NB2009 formula. Which equation to use?
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
October 10, 2025 at 12:08 PM
EKFC or CKD-EPIASR-NB2009 formula. Which equation to use?
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
Dietary vitamin E and tocopherol isoform intake and the progression of CKD
More info: academic.oup.com/ndt/article-...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article-...
@ndt-era.bsky.social, @hjanders.bsky.social
October 9, 2025 at 4:30 PM
Dietary vitamin E and tocopherol isoform intake and the progression of CKD
More info: academic.oup.com/ndt/article-...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article-...
@ndt-era.bsky.social, @hjanders.bsky.social
Acute post-streptococcal glomerulonephritis in children—treatment standard
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
October 8, 2025 at 2:08 PM
Acute post-streptococcal glomerulonephritis in children—treatment standard
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
SGLT2 inhibitors in CKD: are they really effective in all patients?
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
October 7, 2025 at 1:15 PM
SGLT2 inhibitors in CKD: are they really effective in all patients?
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
Review on Renal amyloidosis
More info: academic.oup.com/ndt/article-...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article-...
@ndt-era.bsky.social, @hjanders.bsky.social
October 6, 2025 at 3:34 PM
Review on Renal amyloidosis
More info: academic.oup.com/ndt/article-...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article-...
@ndt-era.bsky.social, @hjanders.bsky.social
IgG4-RD and B cell depletion therapy
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
October 3, 2025 at 12:08 PM
IgG4-RD and B cell depletion therapy
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
More info: academic.oup.com/ndt/article/...
@ndt-era.bsky.social, @hjanders.bsky.social
October 2, 2025 at 4:30 PM